ADRA2A anticorps (C-Term)
Cet anticorps anti-ADRA2A est un anticorps Lapin Polyclonal détectant ADRA2A dans WB, ELISA, IF et IHC. Adapté pour Humain.
N° du produit ABIN2196819
Aperçu rapide pour ADRA2A anticorps (C-Term) (ABIN2196819)
Antigène
Voir toutes ADRA2A Anticorps
ADRA2A
(Alpha-2A Adrenergic Receptor (ADRA2A))
Reactivité
Humain
Hôte
Lapin
Clonalité
Polyclonal
Conjugué
Cet anticorp ADRA2A est non-conjugé
Application
Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (IHC)
-
-
Épitope
-
C-Term
-
Réactivité croisée
-
Humain, Souris, Rat (Rattus)
-
Réactivité croisée (Details)
-
Calculated cross reactivity: Hu Mo Rt
-
Attributs du produit
-
ADRA2A (Alpha-2A Adrenergic Receptor, Alpha-2A Adrenoreceptor, Alpha-2A Adrenoceptor, Alpha-2AAR, ADRA2R, ADRAR)
-
Purification
-
Purified by immunoaffinity chromatography
-
Immunogène
-
Synthetic peptide corresponding to human ADRA2A at C-Terminal.
-
Isotype
-
IgG
-
-
-
Indications d'application
-
Optimal working conditions should be determined by the investigator.
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Buffer
-
Supplied as a liquid in PBS, (without Mg2+, Ca2+), pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol.
-
Agent conservateur
-
Sodium azide
-
Précaution d'utilisation
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
-
-20 °C
-
Stockage commentaire
-
-20°C
-
Antigène
-
ADRA2A
(Alpha-2A Adrenergic Receptor (ADRA2A))
-
Autre désignation
-
ADRA2A
-
Pathways
-
EGFR Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Negative Regulation of Transporter Activity
-